Search
for
Sort by
Research 511–540 of 786
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Hair Loss in Lichen Planopilaris and Frontal Fibrosing Alopecia: Not Always Irreversible
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Genetic Variants and Protective Immunity against SARS-CoV-2
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Whole-genome resequencing to investigate the genetic diversity and the molecular basis underlying key economic traits in indigenous sheep breeds adapted to hypoxic environments
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- Recent Advances in Drug Development for Hair Loss
- Hair Growth Effect of DN106212 in C57BL/6 Mouse and Its Network Pharmacological Mechanism of Action
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- IL-15 Prolongs Anagen, Stimulates Proliferation, and Suppresses Apoptosis in the Hair Matrix of Human Scalp Hair Follicles
- Inflammatory loops in the epithelial–immune microenvironment of the skin and skin appendages in chronic inflammatory diseases
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Skin Pigmentation Types, Causes and Treatment—A Review
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Selection signatures of wool color in Gangba sheep revealed by genome-wide SNP discovery